August 28, 2026
AusperBio
AusperBio is a biotech company developing targeted oligonucleotide therapeutics for the treatment of chronic hepatitis B.
- Round
- Series C
- Amount raised
- $120M
- Lead investor
- —
- Industry
- Biotechnology
- Headquarters
- United States
- Employees
- 51-200 employees
- Website
- ausperbio.com
- View profile →
Source: Google Alerts